Neelesh Heredia

Handelsbanken Wealth & Asset Management Ltd. (Handelsbanken) is a wealth management firm headquartered in London, UK. The firm was founded in 1988 and rebranded as Heartwood Wealth Management Ltd. in 2020. They became a direct wholly owned subsidiary of Handelsbanken Plc in 2013, which is ultimately owned by of Svenska Handelsbanken AB (STO: SHB.A, SHB.B) in Sweden. Handelsbanken manages portfolios for private clients and offers investment management services directly to charities, institutions and individuals through professional intermediaries.

CI Hub Ltd. provides charity services. The private company is based in Liverpool, UK. The British company was founded in 2017 by Lynn Pates, Guy Charles Davies.

GenInvest Limited, a subsidiary of Genesis Housing Group Limited is responsible for investing in and monitoring the Group's non-regulated activities has continued to grow throughout the year. The main investments are through two partnerships with Grainger plc; namely Grainger GenInvest LLP ('GGI1') and Grainger GenInvest (2006) LLP ('GGI2'), which continue to manage a combined portfolio of some 1,600 investment properties providing the Group with a significant gain on the revaluation of those properties.

Anchor Trust is a non profit organization that provides home care services. It offers properties for rent, sales, care homes, and retirement villages. The company was founded in 1968 and is headquartered in London, the United Kingdom.

Mytime Active operates leisure centers and golf courses. The non-profit company is based in Bromley, UK. Marg Mayne has been the CEO of the British company since 2014.

Canford School Ltd. provides educational services. It operates sports centre, sports academy, gulf club and music concerts and events. The company was founded in 1923 and is headquartered in Wimborne, DO.

IVCC is a British company that works to prevent vector-borne diseases and combat insecticide resistance. The private company is based in Liverpool, UK. The company achieves this by directly targeting the vector that transmits the disease. The company's Research & Development Portfolio is dedicated to innovative work that prevents vector-borne diseases and tackles insecticide resistance. IVCC was founded in 2005, and the CEO is Nick Hamon.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.